reference/11543479

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11543479

Outgoing Links

Predicate	Object
contentType	Letter\|Research Support, N.I.H., Extramural
endingPage	336
issn	2522-5812
issueIdentifier	3
pageRange	327-336
publicationName	Nature Metabolism
startingPage	327
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4c2d3dc7b9293ea20d0704607feba8a7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e968c7ad78d7037f6cac1b39e64f0d86 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dd578752ae5937b712b47f67fa424666 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a9995479ea80a0dabd2b72294efe88b2
bibliographicCitation	Xie H, Song J, Godfrey J, Riscal R, Skuli N, Nissim I, Simon MC. Glycogen metabolism is dispensable for tumour progression in clear cell renal cell carcinoma. Nature Metabolism. 2021 Mar 23;3(3):327–36. doi: 10.1038/s42255-021-00367-x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f7b5e02adf17590fa0e4c5a2af05e0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_173c79f02d7530e226e5f4112fad3967 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9106-447X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8969-224X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8195-8602 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0884fe1e32c2d8b03c10b18b8301a13 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6114-9608
date	2021-03-23^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33758423 https://pubmed.ncbi.nlm.nih.gov/PMC7995639 https://doi.org/10.1038/s42255-021-00367-x
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/48119 https://portal.issn.org/resource/ISSN/2522-5812
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Glycogen metabolism is dispensable for tumour progression in clear cell renal cell carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0009463 http://id.nlm.nih.gov/mesh/M0009459
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007680Q000378 http://id.nlm.nih.gov/mesh/D002292Q000378 http://id.nlm.nih.gov/mesh/D006003Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D002292Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006006Q000235 http://id.nlm.nih.gov/mesh/D059016 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D007680Q000235 http://id.nlm.nih.gov/mesh/D002292Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439177 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9cbd768c9e268a076e00c4a20031eef5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eedca9a9c846a5e4a0891ffed8defc22 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ca39045ffbb666252d3a6a6fd7f013a8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 55 of 55.